Eugenio Battaglia

Eugenio Battaglia

Oct 04, 2014

Group 6 Copy 73
0
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Early-Stage Drug Discovery for Chagas' Disease

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

    Targeted Drug Delivery by using Magnetic Nanoparticles

    What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Backer Badge Funded